AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Company provides update on StaphVAX development program.

Vaccine Weekly

| January 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) has continued to advance the development of StaphVAX (Staphylococcus aureus polysaccharide conjugate vaccine) and announced updates to its manufacturing and clinical trial plans.

Currently in a confirmatory phase III clinical trial, StaphVAX is the company's investigational vaccine that is designed to prevent Staphylococcus aureus blood stream infections.

Nabi Biopharmaceuticals continues to make progress towards the manufacture of StaphVAX consistency lots at Cambrex Bio Science, Inc., to support the license application with the European Union planned for the end of 2004.

Capacity at Cambrex can support the launch of StaphVAX in Europe and the initial launch in the U.S. Recognizing that the peak forecasted demand is expected to be substantially ...

Related articles from newspapers, magazines, journals, and more
Nabi Biopharmaceuticals Announces Successful Results from StaphVAX(R)...
Press release article from: PR Newswire October 12, 2005 700+ words
...FirstCall/ -- Nabi Biopharmaceuticals today announced...from its StaphVAX(R) [Staphylococcus...president, Nabi Biopharmaceuticals, stated...commercialization of StaphVAX in Europe...infections. Nabi Biopharmaceuticals is developing StaphVAX for patients...
Nabi Biopharmaceuticals Accelerates Commercialization Plans for StaphVAX(R); EU...
Press release article from: PR Newswire October 9, 2003 700+ words
...the U. S. Nabi Biopharmaceuticals' target for...Application for StaphVAX in the U.S...consistency lots of StaphVAX in a facility...achieve this, Nabi Biopharmaceuticals also announced...concept lot of StaphVAX under this new...pleased that Nabi Biopharmaceuticals ...
Nabi Biopharmaceuticals Initiates StaphVAX(R) Bridging and Consistency Lot...
Press release article from: PR Newswire May 18, 2005 700+ words
...progress with our StaphVAX development programs...but also that Nabi Biopharmaceuticals is reaching those...commercializing StaphVAX in the United...development. Nabi Biopharmaceuticals has advanced StaphVAX(R) [Staphylococcus...
Nabi Biopharmaceuticals Provides Update on StaphVAX(R) Development Program.
Press release article from: PR Newswire December 10, 2003 700+ words
Nabi Biopharmaceuticals has continued...development of StaphVAX(R) [Staphylococcus...announced, Nabi Biopharmaceuticals intends to...licensure of StaphVAX in the European...supply of StaphVAX. Nabi Biopharmaceuticals also announced...
Nabi Biopharmaceuticals Completes Patient Enrollment for StaphVAX(R) Phase III...
Press release article from: PR Newswire August 17, 2004 700+ words
Nabi Biopharmaceuticals today announced...lead program StaphVAX(R) [Staphylococcus...the entire Nabi Biopharmaceuticals team. These...application for StaphVAX by the end...affairs of Nabi Biopharmaceuticals. Dr. Rasmussen...advancing StaphVAX as a potential...
Nabi Biopharmaceuticals Files for European Regulatory Approval for StaphVAX(R)...
Press release article from: PR Newswire December 21, 2004 700+ words
...the marketing of StaphVAX. Upon approval, Nabi Biopharmaceuticals would be allowed to market StaphVAX in all 25 member...About StaphVAX StaphVAX(R) (Staphylococcus...application of Nabi Biopharmaceuticals' vaccine technology...
Nabi Biopharmaceuticals Announces Results of StaphVAX(R) Confirmatory Phase III...
Press release article from: PR Newswire November 1, 2005 700+ words
...FirstCall/ -- Nabi Biopharmaceuticals today announced that StaphVAX(R) [Staphylococcus...however, that StaphVAX was highly...confirming that Nabi Biopharmaceuticals' vaccine...officer, Nabi Biopharmaceuticals, stated...results of the StaphVAX confirmatory...
Nabi Biopharmaceuticals Announces Initiation of New StaphVAX(R) Immunogenicity...
Press release article from: PR Newswire January 6, 2005 700+ words
Nabi Biopharmaceuticals today announced...its U.S. StaphVAX(R) [Staphylococcus...management, Nabi Biopharmaceuticals. "By effectively...infections, StaphVAX could represent...StaphVAX StaphVAX (Staphylococcus...application of Nabi Biopharmaceuticals' ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA